- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-20-0010621

About Acme Progen Biotech (India) Private Limited
Data last updated:
Acme Progen Biotech (India) Private Limited is a private limited company based in Salem, Tamil Nadu, India. It operates in the research and development sector. It was incorporated on 10 July 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U33111TZ2007PTC013847. Its GSTIN is 33AAGCA4241G1Z4 (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Venkatesan Ganesan and Appuchigounder Rathanam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Rams Square 260 G Balaji Nagar Advaitha Ashram Road, Salem, Tamil Nadu, India – 636004.
As per the financials filed for FY 2024, the company reported a revenue of ₹90.39 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹72,839 (net margin 0.8%) and EBITDA of ₹9.6 Lakh (EBITDA margin 10.6%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 2% over five years.
As per MCA filings, the company has satisfied charges of ₹19 Lakh on record.
Acme Progen Biotech (India) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-20-0010621). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website acmeprogen.com.
Company details
Recognitions & Rankings of Acme Progen Biotech (India)
Contact details
Acme Progen Biotech (India) Private Limited's registered office is in Salem, Tamil Nadu. Its website is acmeprogen.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressRams Square 260 G Balaji Nagar Advaitha Ashram Road, Salem, Tamil Nadu, India – 636004
- IndustryResearch & Development, Research & Development
To see the full contact details of Acme Progen Biotech (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Acme Progen Biotech (India) is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Acme Progen Biotech (India) Private Limited, buy the company report.
Financials of Acme Progen Biotech (India) Private Limited
FY 2025 filings availableAcme Progen Biotech (India) Private Limited reported revenue of ₹90.39 Lakh (up 9% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 9% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.6 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹72,839 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.6% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Acme Progen Biotech (India) Private Limited, buy the company report.
Board of directors of Acme Progen Biotech (India) Private Limited
Acme Progen Biotech (India) has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkatesan Ganesan | Director | 30 Nov 2021 | 4 Years 11 Months | Current |
| Appuchigounder Rathanam | Director | 04 Apr 2018 | 8 Years 7 Months | Current |
| Mani Chitra | Director | 10 Jul 2007 | 19 Years 4 Months | Current |
Peer comparison
Acme Progen Biotech (India) Private Limited is compared with the 8 companies closest to it by revenue in the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aindra Systems Private Limited | ₹91.19 Lakh (FY 2024) | 195.0% | Bengaluru, Karnataka, India | |||
| Serigen Mediproducts Private Limited | ₹91.08 Lakh (FY 2025) | 338.0% | Pune, Maharashtra, India | |||
| Mithra Increst Private Limited | ₹90.93 Lakh (FY 2024) | -89.0% | Bangalore, Karnataka, India | |||
| JK Material Test House Infracon and Consultancy Private Limited | ₹90.46 Lakh (FY 2025) | 327.0% | Rajauri, Jammu and Kashmir, India | |||
| Acme Progen Biotech (India) Private Limitedthis company | ₹90.39 Lakh (FY 2024) | ₹72,839 | 0.8% | 9.0% | Salem, Tamil Nadu, India | |
| Paryani Diagnostics Centre Private Limited | ₹90.23 Lakh (FY 2025) | 7.0% | Indore, Madhya Pradesh, India | |||
| Evoscien Private Limited | ₹89.99 Lakh (FY 2025) | -7.0% | Bengaluru, Karnataka, India | |||
| Indglobl Nextgen Medicare Limited | ₹88.5 Lakh (FY 2019) | 53.0% | Chengalpattu, Tamil Nadu, India | |||
| QCC Lab Solutions Private Limited | ₹88.14 Lakh (FY 2025) | -15.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Acme Progen Biotech (India) Private Limited, buy the company report.
Auditor
Acme Progen Biotech (India) Private Limited is audited by M SEKAR for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M SEKAR | FY 2017 | 215473 |
Shareholding
The shareholding of Acme Progen Biotech (India) Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Acme Progen Biotech (India) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jun 2018 | 100212631 | Indian Bank | ₹10 Lakh | Satisfied | |
| 05 Dec 2007 | 10109353 | The Lakshmi Vilas Bank Ltd | ₹9 Lakh | Satisfied |
To see the full charge records of Acme Progen Biotech (India) Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Acme Progen Biotech (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Acme Progen Biotech (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Acme Progen Biotech (India) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAGCA4241G1Z4 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Acme Progen Biotech (India) Private Limited, buy the company report.
Recent activity
Acme Progen Biotech (India) Private Limited has 6 board changes on record since 2007: 3 appointments and 3 cessations. The latest: Venkatesan Ganesan was appointed as Director on 30 Nov 2021.
2 earlier events are in the company report.
Frequently asked questions
Acme Progen Biotech (India) is an active private limited company based in Salem, Tamil Nadu, India. The company works in the research and development industry. It was incorporated on 10 July 2007 (19+ years old) and is registered under CIN U33111TZ2007PTC013847.
Acme Progen Biotech (India) has 3 current directors:
- Venkatesan Ganesan - Director
- Appuchigounder Rathanam - Director
- Mani Chitra - Director
The latest financial statements of Acme Progen Biotech (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Acme Progen Biotech (India) is 33AAGCA4241G1Z4, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Acme Progen Biotech (India) is U33111TZ2007PTC013847. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Acme Progen Biotech (India) was incorporated on 10 July 2007, making it 19+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of Acme Progen Biotech (India) by revenue are Aindra Systems Private Limited, Serigen Mediproducts Private Limited, Mithra Increst Private Limited, JK Material Test House Infracon and Consultancy Private Limited, Paryani Diagnostics Centre Private Limited and 3 more, all in the same principal business activity (scientific research and development).
Venkatesan Ganesan was appointed as Director on 30 Nov 2021. Appuchigounder Rathanam ceased to be Additional Director on 29 Sep 2018. Appuchigounder Rathanam was appointed as Director on 04 Apr 2018. Acme Progen Biotech (India) has 6 board changes on record in total.
Yes, Acme Progen Biotech (India) is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-20-0010621).
Acme Progen Biotech (India) can be reached through the website acmeprogen.com. Its registered office is in Salem, Tamil Nadu, India.
The registered office of Acme Progen Biotech (India) is at Rams Square 260 G Balaji Nagar Advaitha Ashram Road, Salem, Tamil Nadu, India – 636004.

